| Expression of SLC22A1 variants may affect the response of hepatocellular carcinoma and cholangiocarcinoma to sorafenib E Herraez, E Lozano, RIR Macias, J Vaquero, L Bujanda, JM Banales, ... Hepatology 58 (3), 1065-1073, 2013 | 166 | 2013 |
| Mechanisms of resistance to chemotherapy in gastric cancer JJG Marin, R Al-Abdulla, E Lozano, O Briz, L Bujanda, J M Banales, ... Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2016 | 152 | 2016 |
| Chemoresistance and chemosensitization in cholangiocarcinoma JJG Marin, E Lozano, E Herraez, M Asensio, S Di Giacomo, MR Romero, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1864 (4 …, 2018 | 124 | 2018 |
| Is plasma cardiotrophin-1 a marker of hypertensive heart disease? B López, A González, JJ Lasarte, P Sarobe, F Borrás, A Díaz, J Barba, ... Journal of hypertension 23 (3), 625-632, 2005 | 123 | 2005 |
| No correlation between the expression of FXR and genes involved in multidrug resistance phenotype of primary liver tumors P Martinez-Becerra, J Vaquero, MR Romero, E Lozano, C Anadon, ... Molecular Pharmaceutics 9 (6), 1693-1704, 2012 | 99 | 2012 |
| The search for novel diagnostic and prognostic biomarkers in cholangiocarcinoma RIR Macias, JM Banales, B Sangro, J Muntané, MA Avila, E Lozano, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1864 (4 …, 2018 | 96 | 2018 |
| Cocarcinogenic effects of intrahepatic bile acid accumulation in cholangiocarcinoma development E Lozano, L Sanchez-Vicente, MJ Monte, E Herraez, O Briz, JM Banales, ... Molecular Cancer Research 12 (1), 91-100, 2014 | 85 | 2014 |
| Molecular bases of the poor response of liver cancer to chemotherapy JJG Marin, O Briz, E Herraez, E Lozano, M Asensio, S Di Giacomo, ... Clinics and Research in Hepatology and Gastroenterology 42 (3), 182-192, 2018 | 82 | 2018 |
| Role of the plasma membrane transporter of organic cations OCT1 and its genetic variants in modern liver pharmacology E Lozano, E Herraez, O Briz, VS Robledo, J Hernandez-Iglesias, ... BioMed research international 2013 (1), 692071, 2013 | 82 | 2013 |
| Signalling networks in cholangiocarcinoma: Molecular pathogenesis, targeted therapies and drug resistance L Fouassier, M Marzioni, MB Afonso, S Dooley, K Gaston, G Giannelli, ... Liver International 39, 43-62, 2019 | 72 | 2019 |
| Usefulness of plasma cardiotrophin-1 in assessment of left ventricular hypertrophy regression in hypertensive patients A Gonzalez, B López, D Martín-Raymondi, E Lozano, N Varo, J Barba, ... Journal of hypertension 23 (12), 2297-2304, 2005 | 70 | 2005 |
| Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseases AD Urribarri, P Munoz-Garrido, MJ Perugorria, O Erice, ... Gut 63 (10), 1658-1667, 2014 | 65 | 2014 |
| Molecular bases of chemoresistance in cholangiocarcinoma J JG Marin, E Lozano, O Briz, R Al-Abdulla, M A Serrano, R IR Macias Current Drug Targets 18 (8), 889-900, 2017 | 61 | 2017 |
| Causes of hOCT1‐dependent cholangiocarcinoma resistance to sorafenib and sensitization by tumor‐selective gene therapy E Lozano, RIR Macias, MJ Monte, M Asensio, S Del Carmen, ... Hepatology 70 (4), 1246-1261, 2019 | 59 | 2019 |
| Chemosensitization of hepatocellular carcinoma cells to sorafenib by β-caryophyllene oxide-induced inhibition of ABC export pumps S Di Giacomo, O Briz, MJ Monte, L Sanchez-Vicente, L Abete, E Lozano, ... Archives of Toxicology 93, 623-634, 2019 | 56 | 2019 |
| Epigenetic events involved in organic cation transporter 1‐dependent impaired response of hepatocellular carcinoma to sorafenib R Al‐Abdulla, E Lozano, RIR Macias, MJ Monte, O Briz, CJ O'Rourke, ... British Journal of Pharmacology 176 (6), 787-800, 2019 | 53 | 2019 |
| Enhanced antitumour drug delivery to cholangiocarcinoma through the apical sodium-dependent bile acid transporter (ASBT) E Lozano, MJ Monte, O Briz, A Hernández-Hernández, JM Banales, ... Journal of controlled release 216, 93-102, 2015 | 51 | 2015 |
| Role of macrophages in bile acid-induced inflammatory response of fetal lung during maternal cholestasis E Herraez, E Lozano, E Poli, V Keitel, D De Luca, C Williamson, ... Journal of Molecular Medicine 92, 359-372, 2014 | 50 | 2014 |
| Mechanisms of anticancer drug resistance in hepatoblastoma JJG Marin, C Cives-Losada, M Asensio, E Lozano, O Briz, RIR Macias Cancers 11 (3), 407, 2019 | 49 | 2019 |
| Protective role of biliverdin against bile acid-induced oxidative stress in liver cells E Gonzalez-Sanchez, MJ Perez, NS Nytofte, O Briz, MJ Monte, E Lozano, ... Free Radical Biology and Medicine 97, 466-477, 2016 | 46 | 2016 |
